Global Acute External Ventricular Drain Market Growth 2025-2031

Publication ID:

LPI04255095

Publication Date:

April 23, 2025

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Acute External Ventricular Drain market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
听A temporary system that allows drainage of cerebral spinal fluid (CSF) from the ventricles to an external closed system.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The 鈥淎cute External Ventricular Drain Industry Forecast鈥� looks at past sales and reviews total world Acute External Ventricular Drain sales in 2024, providing a comprehensive analysis by region and market sector of projected Acute External Ventricular Drain sales for 2025 through 2031. With Acute External Ventricular Drain sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute External Ventricular Drain industry.
This Insight Report provides a comprehensive analysis of the global Acute External Ventricular Drain landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute External Ventricular Drain portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Acute External Ventricular Drain market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute External Ventricular Drain and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute External Ventricular Drain.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute External Ventricular Drain market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Aldult
Child
Segmentation by Application:
Intracerebral Hemorrhage
Nontraumatic Hydrocephalus
Subarachnoid Hemorrhage
Traumatic Brain Injury
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
B Braun
Bicakcilar
Brain Navi
Cadila Pharm
Dispomedica
Fuji Systems
Geistlich Pharma
Integra LifeSciences
Johnson and Johnson
Medtronic
Moller Medical
Natus Medical
Neuromedex
Nipro
Pfizer
Key Questions Addressed in this Report
What is the 10-year outlook for the global Acute External Ventricular Drain market?
What factors are driving Acute External Ventricular Drain market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acute External Ventricular Drain market opportunities vary by end market size?
How does Acute External Ventricular Drain break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Acute External Ventricular Drain Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Acute External Ventricular Drain by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Acute External Ventricular Drain by Country/Region, 2020, 2024 & 2031
2.2 Acute External Ventricular Drain Segment by Type
2.2.1 Aldult
2.2.2 Child
2.3 Acute External Ventricular Drain Sales by Type
2.3.1 Global Acute External Ventricular Drain Sales Market Share by Type (2020-2025)
2.3.2 Global Acute External Ventricular Drain Revenue and Market Share by Type (2020-2025)
2.3.3 Global Acute External Ventricular Drain Sale Price by Type (2020-2025)
2.4 Acute External Ventricular Drain Segment by Application
2.4.1 Intracerebral Hemorrhage
2.4.2 Nontraumatic Hydrocephalus
2.4.3 Subarachnoid Hemorrhage
2.4.4 Traumatic Brain Injury
2.5 Acute External Ventricular Drain Sales by Application
2.5.1 Global Acute External Ventricular Drain Sale Market Share by Application (2020-2025)
2.5.2 Global Acute External Ventricular Drain Revenue and Market Share by Application (2020-2025)
2.5.3 Global Acute External Ventricular Drain Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Acute External Ventricular Drain Breakdown Data by Company
3.1.1 Global Acute External Ventricular Drain Annual Sales by Company (2020-2025)
3.1.2 Global Acute External Ventricular Drain Sales Market Share by Company (2020-2025)
3.2 Global Acute External Ventricular Drain Annual Revenue by Company (2020-2025)
3.2.1 Global Acute External Ventricular Drain Revenue by Company (2020-2025)
3.2.2 Global Acute External Ventricular Drain Revenue Market Share by Company (2020-2025)
3.3 Global Acute External Ventricular Drain Sale Price by Company
3.4 Key Manufacturers Acute External Ventricular Drain Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acute External Ventricular Drain Product Location Distribution
3.4.2 Players Acute External Ventricular Drain Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Acute External Ventricular Drain by Geographic Region
4.1 World Historic Acute External Ventricular Drain Market Size by Geographic Region (2020-2025)
4.1.1 Global Acute External Ventricular Drain Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Acute External Ventricular Drain Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Acute External Ventricular Drain Market Size by Country/Region (2020-2025)
4.2.1 Global Acute External Ventricular Drain Annual Sales by Country/Region (2020-2025)
4.2.2 Global Acute External Ventricular Drain Annual Revenue by Country/Region (2020-2025)
4.3 Americas Acute External Ventricular Drain Sales Growth
4.4 APAC Acute External Ventricular Drain Sales Growth
4.5 Europe Acute External Ventricular Drain Sales Growth
4.6 Middle East & Africa Acute External Ventricular Drain Sales Growth
5 Americas
5.1 Americas Acute External Ventricular Drain Sales by Country
5.1.1 Americas Acute External Ventricular Drain Sales by Country (2020-2025)
5.1.2 Americas Acute External Ventricular Drain Revenue by Country (2020-2025)
5.2 Americas Acute External Ventricular Drain Sales by Type (2020-2025)
5.3 Americas Acute External Ventricular Drain Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute External Ventricular Drain Sales by Region
6.1.1 APAC Acute External Ventricular Drain Sales by Region (2020-2025)
6.1.2 APAC Acute External Ventricular Drain Revenue by Region (2020-2025)
6.2 APAC Acute External Ventricular Drain Sales by Type (2020-2025)
6.3 APAC Acute External Ventricular Drain Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Acute External Ventricular Drain by Country
7.1.1 Europe Acute External Ventricular Drain Sales by Country (2020-2025)
7.1.2 Europe Acute External Ventricular Drain Revenue by Country (2020-2025)
7.2 Europe Acute External Ventricular Drain Sales by Type (2020-2025)
7.3 Europe Acute External Ventricular Drain Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Acute External Ventricular Drain by Country
8.1.1 Middle East & Africa Acute External Ventricular Drain Sales by Country (2020-2025)
8.1.2 Middle East & Africa Acute External Ventricular Drain Revenue by Country (2020-2025)
8.2 Middle East & Africa Acute External Ventricular Drain Sales by Type (2020-2025)
8.3 Middle East & Africa Acute External Ventricular Drain Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acute External Ventricular Drain
10.3 Manufacturing Process Analysis of Acute External Ventricular Drain
10.4 Industry Chain Structure of Acute External Ventricular Drain
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acute External Ventricular Drain Distributors
11.3 Acute External Ventricular Drain Customer
12 World Forecast Review for Acute External Ventricular Drain by Geographic Region
12.1 Global Acute External Ventricular Drain Market Size Forecast by Region
12.1.1 Global Acute External Ventricular Drain Forecast by Region (2026-2031)
12.1.2 Global Acute External Ventricular Drain Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Acute External Ventricular Drain Forecast by Type (2026-2031)
12.7 Global Acute External Ventricular Drain Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 B Braun
13.1.1 B Braun Company Information
13.1.2 B Braun Acute External Ventricular Drain Product Portfolios and Specifications
13.1.3 B Braun Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 B Braun Main Business Overview
13.1.5 B Braun Latest Developments
13.2 Bicakcilar
13.2.1 Bicakcilar Company Information
13.2.2 Bicakcilar Acute External Ventricular Drain Product Portfolios and Specifications
13.2.3 Bicakcilar Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bicakcilar Main Business Overview
13.2.5 Bicakcilar Latest Developments
13.3 Brain Navi
13.3.1 Brain Navi Company Information
13.3.2 Brain Navi Acute External Ventricular Drain Product Portfolios and Specifications
13.3.3 Brain Navi Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Brain Navi Main Business Overview
13.3.5 Brain Navi Latest Developments
13.4 Cadila Pharm
13.4.1 Cadila Pharm Company Information
13.4.2 Cadila Pharm Acute External Ventricular Drain Product Portfolios and Specifications
13.4.3 Cadila Pharm Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cadila Pharm Main Business Overview
13.4.5 Cadila Pharm Latest Developments
13.5 Dispomedica
13.5.1 Dispomedica Company Information
13.5.2 Dispomedica Acute External Ventricular Drain Product Portfolios and Specifications
13.5.3 Dispomedica Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Dispomedica Main Business Overview
13.5.5 Dispomedica Latest Developments
13.6 Fuji Systems
13.6.1 Fuji Systems Company Information
13.6.2 Fuji Systems Acute External Ventricular Drain Product Portfolios and Specifications
13.6.3 Fuji Systems Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Fuji Systems Main Business Overview
13.6.5 Fuji Systems Latest Developments
13.7 Geistlich Pharma
13.7.1 Geistlich Pharma Company Information
13.7.2 Geistlich Pharma Acute External Ventricular Drain Product Portfolios and Specifications
13.7.3 Geistlich Pharma Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Geistlich Pharma Main Business Overview
13.7.5 Geistlich Pharma Latest Developments
13.8 Integra LifeSciences
13.8.1 Integra LifeSciences Company Information
13.8.2 Integra LifeSciences Acute External Ventricular Drain Product Portfolios and Specifications
13.8.3 Integra LifeSciences Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Integra LifeSciences Main Business Overview
13.8.5 Integra LifeSciences Latest Developments
13.9 Johnson and Johnson
13.9.1 Johnson and Johnson Company Information
13.9.2 Johnson and Johnson Acute External Ventricular Drain Product Portfolios and Specifications
13.9.3 Johnson and Johnson Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Johnson and Johnson Main Business Overview
13.9.5 Johnson and Johnson Latest Developments
13.10 Medtronic
13.10.1 Medtronic Company Information
13.10.2 Medtronic Acute External Ventricular Drain Product Portfolios and Specifications
13.10.3 Medtronic Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Medtronic Main Business Overview
13.10.5 Medtronic Latest Developments
13.11 Moller Medical
13.11.1 Moller Medical Company Information
13.11.2 Moller Medical Acute External Ventricular Drain Product Portfolios and Specifications
13.11.3 Moller Medical Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Moller Medical Main Business Overview
13.11.5 Moller Medical Latest Developments
13.12 Natus Medical
13.12.1 Natus Medical Company Information
13.12.2 Natus Medical Acute External Ventricular Drain Product Portfolios and Specifications
13.12.3 Natus Medical Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Natus Medical Main Business Overview
13.12.5 Natus Medical Latest Developments
13.13 Neuromedex
13.13.1 Neuromedex Company Information
13.13.2 Neuromedex Acute External Ventricular Drain Product Portfolios and Specifications
13.13.3 Neuromedex Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Neuromedex Main Business Overview
13.13.5 Neuromedex Latest Developments
13.14 Nipro
13.14.1 Nipro Company Information
13.14.2 Nipro Acute External Ventricular Drain Product Portfolios and Specifications
13.14.3 Nipro Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Nipro Main Business Overview
13.14.5 Nipro Latest Developments
13.15 Pfizer
13.15.1 Pfizer Company Information
13.15.2 Pfizer Acute External Ventricular Drain Product Portfolios and Specifications
13.15.3 Pfizer Acute External Ventricular Drain Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Pfizer Main Business Overview
13.15.5 Pfizer Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂